Abstract
Soft tissue sarcomas (STS) are a heterogeneous group of malignancies of mesenchymal origin with an incidence of 4-8 per 100,000 within Europe, consist of various subtypes, each expressing distinct morphological, histopathological and molecular features. According to the 2020 WHO classification, STS are divided into 11 broad categories comprising approximately 80 entities. STS management guidelines are constantly evolving due to the development of newer diagnostic methods and treatments including the discovery of new chemotherapeutic agents and immunomodulators. Although the referral, diagnostic and management pathways may vary in different healthcare systems, the core management principles remain the same.This article explores various established STS guidelines on imaging diagnosis, staging and follow-up by international societies. It also describes radiologic utility in assessing recurrence and post-operative mimics. The objective is to provide radiologists and clinicians with imaging guidance useful at various stages of STS management.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
